Global MRI-guided Radiation Therapy Systems Market Size By Type (0.5 T, 1.5 T), By Application (Hospitals, Radiotherapy Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global MRI-guided Radiation Therapy Systems Market was valued at USD 754 million in 2023 and is projected to reach USD 1.8 billion by 2031, growing at a CAGR of 11.2% during the forecast period from 2023 to 2031. MRI-guided radiation therapy (MRIgRT) represents a major breakthrough in precision oncology, combining magnetic resonance imaging (MRI) with radiation therapy to enhance tumor targeting while minimizing damage to healthy tissues. This market is driven by the growing prevalence of cancer worldwide, increasing demand for non-invasive and personalized treatment approaches, and technological advancements in imaging-guided therapy systems.

Drivers:

Rising Cancer Incidence:

The increasing global burden of cancer is the primary driver for MRI-guided radiation therapy systems. With millions of new cancer cases diagnosed each year, the demand for advanced, accurate, and patient-friendly treatment options continues to surge.

Technological Innovations in Radiation Oncology:

Advancements such as real-time imaging, adaptive therapy, and high-definition magnetic resonance imaging are enhancing the capabilities of MRIgRT systems. These innovations support better treatment planning and increased safety, fueling market growth.

Shift Towards Personalized Medicine:

The movement toward patient-specific treatment regimens in oncology has amplified the adoption of MRIgRT systems. These systems allow for adaptive radiation therapy tailored to the individual’s anatomy and tumor characteristics in real time.

Restraints:

High Cost of Equipment and Installation:

The high acquisition and operational costs of MRIgRT systems present a significant barrier, especially for smaller hospitals and clinics in developing regions. Installation also demands specific infrastructure and shielding, adding to overall expenses.

Limited Availability of Skilled Professionals:

Effective use of MRI-guided systems requires trained professionals including radiation oncologists, physicists, and radiologists. A lack of such expertise can limit the adoption of these systems in many regions.

Opportunity:

Expansion in Emerging Markets:

As healthcare infrastructure develops in Asia-Pacific, Latin America, and the Middle East, emerging economies present lucrative opportunities for MRIgRT system manufacturers. Government investments in oncology care and favorable reimbursement policies are supporting market entry.

Integration with Artificial Intelligence:

The integration of AI for real-time image analysis and adaptive treatment planning enhances the efficiency of MRIgRT systems. AI-driven innovations can optimize workflow, reduce treatment time, and improve patient outcomes, offering immense market potential.

Market by System Type Insights:

The Hybrid MRI-Linac Systems segment accounted for the largest market share in 2023. These systems combine linear accelerators with MRI imaging for real-time tumor tracking and radiation delivery, providing high precision and adaptability during treatment. The segment continues to dominate due to its versatility, accuracy, and growing preference in high-volume oncology centers.

Market by End-use Insights:

In terms of end use, the Hospitals & Cancer Treatment Centers segment held over 65% of the market share in 2023. These facilities are the primary adopters of MRI-guided systems due to their comprehensive infrastructure, specialized staff, and high patient throughput. Meanwhile, research institutes are emerging as fast-growing end-users, driven by ongoing clinical trials and product development.

Market by Regional Insights:

North America led the market in 2023, driven by strong healthcare infrastructure, high awareness of advanced cancer treatments, and the presence of major players like ViewRay and Elekta. However, the Asia-Pacific region is projected to experience the fastest growth during the forecast period, supported by rising healthcare investments, expanding cancer incidence, and adoption of precision medicine in countries like China, India, and Japan.

Competitive Scenario:

Key players operating in the Global MRI-guided Radiation Therapy Systems Market include:

ViewRay, Inc.

Elekta AB

Siemens Healthineers AG

GE Healthcare

Hitachi Ltd.

Canon Medical Systems Corporation

Accuray Incorporated

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Varian Medical Systems (a Siemens Healthineers company)

These companies focus on product development, regulatory approvals, strategic partnerships, and geographical expansion. For example:

In 2023, ViewRay introduced MRIdian A3i, its most advanced system yet, with adaptive therapy capabilities and improved real-time imaging.

In 2024, Elekta announced a partnership with major oncology centers in Europe to expand access to its Unity MR-Linac platform.

Scope of Work – Global MRI-guided Radiation Therapy Systems Market

Report Metric Details

Market Size (2023) USD 754 million

Projected Market Size (2031) USD 1.8 billion

CAGR (2023–2031) 11.2%

Market Segments System Type, End-use, Region

Growth Drivers Rising cancer incidence, technological advancements in radiotherapy, and increasing demand for precision oncology

Opportunities Expansion in emerging markets, AI integration in radiation therapy

Key Market Developments:

June 2023: ViewRay received FDA clearance for the MRIdian A3i system with advanced real-time tracking and adaptive therapy tools.

October 2023: Elekta entered a multi-year agreement with leading hospitals in Japan to install Unity MRI-guided radiation systems.

March 2024: Siemens Healthineers launched a collaborative research initiative to explore AI-enabled MRIgRT in partnership with top oncology institutions in Europe.

FAQs:

What is the current market size of the Global MRI-guided Radiation Therapy Systems Market?

The market was valued at USD 754 million in 2023.

What is the major growth driver of the Global MRI-guided Radiation Therapy Systems Market?

Rising global cancer incidence and demand for precision oncology treatments.

Which is the largest region during the forecast period in the Global MRI-guided Radiation Therapy Systems Market?

North America holds the largest market share.

Which segment accounted for the largest market share in the Global MRI-guided Radiation Therapy Systems Market?

The Hybrid MRI-Linac Systems segment.